1 May 2026Potentially dangerous, obsolete, or ineffective
Long-acting oily chloramphenicol injectable
Long-acting oily chloramphenicol guidance for meningococcal meningitis during epidemics, with single-dose IM use and haematologic precautions.
Prescription under medical supervision
This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.
Therapeutic action
Phenicol antibacterial, with prolonged effect.
Indications
Treatment of meningococcal meningitis during epidemics.
Forms and strengths, route of administration
500 mg oily suspension in 2 ml ampoule (250 mg/ml) for IM injection only.
Dosage
Child over 2 years and adult: 100 mg/kg single dose (max. 3 g per dose).
- 2 to under 6 years, 13 to under 21 kg: 1.5 g (6 ml).
- 6 to under 10 years, 21 to under 31 kg: 2 g (8 ml).
- 10 to under 15 years, 31 to under 54 kg: 2.5 g (10 ml).
- 15 years and over and adult, 54 kg and over: 3 g (12 ml).
- If necessary, administer half the dose into each buttock.
| Age | Weight | Dose | Volume |
|---|---|---|---|
| 2 to < 6 years | 13 to < 21 kg | 1.5 g | 6 ml |
| 6 to < 10 years | 21 to < 31 kg | 2 g | 8 ml |
| 10 to < 15 years | 31 to < 54 kg | 2.5 g | 10 ml |
| ≥ 15 years and adult | ≥ 54 kg | 3 g | 12 ml |
Duration
Single dose. If there is no improvement after 24 hours, a second dose may be administered.
Contra-indications, adverse effects, precautions
- Do not administer to patients with history of allergic reaction or bone marrow depression during a previous treatment with chloramphenicol, or with G6PD deficiency.
- May cause dose-related haematological toxicity, allergic reactions, gastrointestinal disturbances, and peripheral or optic neuropathies.
- Avoid or monitor combination with potentially haematotoxic drugs such as carbamazepine, co-trimoxazole, flucytosine, pyrimethamine, and zidovudine.
- Pregnancy: contraindicated.
- Breast-feeding: contraindicated.
Source
MSF Essential drugs practical guidelines (January 2026)
This page reproduces the structured reference information for this batch while leaving out the Storage and Remarks sections.
Rate this guide
Be the first to rate this guide.
